About Anbio Biotechnology (NNNN) data
Data as of September 30, 2026.
Anbio Biotechnology (NNNN) has 54.02K shares sold short as of the latest FINRA settlement report on September 30, 2026. Short interest has increased by 4.55% compared with the prior settlement. At the current average daily volume, covering all open short positions would take about 0.26 days (days to cover).
Frequently asked questions
What is the current short interest in NNNN?
As of the latest FINRA settlement dated September 30, 2026, NNNN had approximately 54,022 shares sold short. Short interest data is reported by FINRA twice per month.
How much does it cost to short NNNN?
The latest borrow fee (cost to borrow) for NNNN is 116.49% per year, based on IBKR data. Fees can change throughout the trading day as shares are borrowed and returned.
What is the days to cover ratio for NNNN?
Days to cover for NNNN is approximately 0.26 days. This estimates how many trading days it would take short sellers to buy back all outstanding short shares at the current average daily volume.
How many NNNN shares failed to deliver?
On September 30, 2026, the latest settlement date in the SEC's fails-to-deliver data, 94 shares of NNNN had failed to deliver, worth about $579.04 at the prior day's close (under 0.01% of shares outstanding). That is the balance still outstanding that day, not new fails. Fails come from long sales and delivery delays as well as short sales.
Is NNNN a short squeeze candidate?
A squeeze needs shorts that are hard to close. NNNN trades about 204,550 shares a day and would take roughly 0.26 days to unwind current short positions, at a current borrow fee of 116.49%. Higher days-to-cover and a rising borrow fee together are the setup to watch; neither alone is enough.